University of Arizona- Tuscon

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, allergic disease, chronic obstructive pulmonary disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder	Recruiting	Phase 2	2026-09-04		NCT07059091

Clinical trials